More threads by Andy

Andy

MVP
Common anesthetic is anti-depressant 'wonder drug': study - Yahoo! Canada News
Thu Aug 19, 2010

WASHINGTON (AFP) - Ketamine, a general anesthetic usually administered to children and pets, is also highly effective in low doses as an anti-depressant, according a study published Thursday.

Researchers at Yale University wrote in the August 20 issue of the journal Science that unlike most anti-depressants on the market which can take weeks to take full effect ketamine can begin to counter depression in hours.

"It's like a magic drug -- one dose can work rapidly and last for seven to 10 days," said Ronald Duman, professor of psychiatry and pharmacology at Yale and senior author of the study.

The researchers noted that ketamine was tested as a rapid treatment for people with suicidal thoughts. Traditional anti-depressants can take several weeks to take effect, they noted.

About 40 percent of people suffering from depression do not respond to medication, and many others only respond after many months or years of trying different treatments.

The researchers found that ketamine improves depression-like behavior in rats by restoring connections between brain cells damaged by chronic stress.

"The pathway is the story. Understanding the mechanism underlying the anti-depressant effect of ketamine will allow us to attack the problem at a variety of possible sites within that pathway," said George Aghajanian, another Yale scientist, who co-authored the study.

Clinical use of ketamine has been limited because it has to be delivered intravenously under medical supervision and in some cases can cause short-term psychotic symptoms.

The National Institute of Mental Health found in a separate study that almost 70 percent of patients resistant to treatment with all other forms of anti-depressants were found to improve within hours after receiving ketamine.
 

Andy

MVP
Re: Study of Common anesthetic is anti-depressant 'wonder drug'

I really don't think this is a good idea at all.
If doses are given out by a doctor and the drug never leaves their hands then fine (as if). This is a street drug (special K, Ket, K...)as well and if it becomes even more accessible I think it will cause all kinds of problems. It's extremely dangerous if you don't know what your doing, well even if you think you do.

Anyway, my 2 cents. I think it's a really bad idea.
 

David Baxter PhD

Late Founder
Ketamine for Treatment-Resistant Bipolar Depression?
By Candida Fink MD
August 19, 2010

A recent study published in the Archives of General Psychiatry by researchers at National Institute of Mental Health showed that the medication Ketamine, given intravenously to a small group of people with bipolar depression, caused a rapid antidepressant response in a high percentage of those patients. Their responses were much better than patients given a placebo IV solution.

The purpose of this study was to look at a specific type of neurotransmitter – glutamate – that is different than any of the transmitters that our current medications target. The question being asked was whether targeting these particular receptors might provide more rapid relief of depressive symptoms specifically in people with bipolar depression. There have been several previous studies showing a rapid, strong antidepressant response to IV-administered Ketamine in people with depression, but this is the first study to look at these receptors in bipolar depression specifically.

The benefits from the Ketamine lasted an average of 6.8 days, and while one patient on Ketamine became manic, so did one patient on placebo. The side effects included some initial periods of dissociation and changes in perception – these effects were brief, and not everyone experienced them. Ketamine is used recreationally (as the club drug known as Special K) to get these perceptual and dissociative feelings. This is not discussed in the study but is something to be considered if Ketamine is going to be further evaluated as a potential treatment for depression.

The study is valuable because it adds something to our understanding of the neurochemistry of bipolar disorder and possible new treatment approaches. This study isn’t suggesting that intravenous Ketamine be used in a clinical setting to treat bipolar depression, but it is expanding our knowledge of ways to treat it – and in particular – possibly ways to treat depression much more quickly than we do with our currently available medications. There is a lot of active research on the glutamate system and it is likely to be the next big wave of new interventions for depression.
 
Replying is not possible. This forum is only available as an archive.
Top